PL364768A1 - Analogi witaminy D - Google Patents

Analogi witaminy D

Info

Publication number: PL364768A1
Authority: PL; Poland
Prior art keywords: analogues; vitamin
Prior art date: 1999-11-24

Application number

PL00364768A

Other languages

English (en)

Other versions

PL207046B1 (pl

Inventor

Jean-Michel Bernardon

Thibaud Biadatti

Original Assignee

Galderma Research & Development, S.N.C.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-24

Filing date

2000-11-22

Publication date

2004-12-13

2000-11-22 Application filed by Galderma Research & Development, S.N.C. filed Critical Galderma Research & Development, S.N.C.

2004-12-13 Publication of PL364768A1 publication Critical patent/PL364768A1/pl

2010-10-29 Publication of PL207046B1 publication Critical patent/PL207046B1/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/19—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Gerontology & Geriatric Medicine (AREA)
Birds (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Nutrition Science (AREA)
Transplantation (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL364768A 1999-11-24 2000-11-22 Triaromatyczne analogi witaminy D, ich zastosowanie i kompozycje farmaceutyczne je zawierające PL207046B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9914781A FR2801305B1 (fr)	1999-11-24	1999-11-24	Analogues de la vitamine d
PCT/FR2000/003249 WO2001038303A2 (fr)	1999-11-24	2000-11-22	Analogues de la vitamine d

Publications (2)

Publication Number	Publication Date
PL364768A1 true PL364768A1 (pl)	2004-12-13
PL207046B1 PL207046B1 (pl)	2010-10-29

Family

ID=9552483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL364768A PL207046B1 (pl)	1999-11-24	2000-11-22	Triaromatyczne analogi witaminy D, ich zastosowanie i kompozycje farmaceutyczne je zawierające

Country Status (22)

Country	Link
US (1)	US6831106B1 (pl)
EP (1)	EP1235777B1 (pl)
JP (1)	JP3822106B2 (pl)
KR (1)	KR100599069B1 (pl)
CN (2)	CN1213980C (pl)
AR (1)	AR043279A1 (pl)
AT (1)	ATE269289T1 (pl)
AU (1)	AU767399B2 (pl)
BR (1)	BR0015924A (pl)
CA (1)	CA2392165C (pl)
DE (1)	DE60011669T2 (pl)
DK (1)	DK1235777T3 (pl)
ES (1)	ES2223642T3 (pl)
FR (1)	FR2801305B1 (pl)
MX (1)	MXPA02005175A (pl)
PL (1)	PL207046B1 (pl)
PT (1)	PT1235777E (pl)
RU (1)	RU2237651C2 (pl)
SE (1)	SE1235777T5 (pl)
TR (1)	TR200401603T4 (pl)
WO (1)	WO2001038303A2 (pl)
ZA (1)	ZA200203475B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2833258B1 (fr) *	2001-12-10	2004-08-27	Galderma Res & Dev	Analogues de la vitamine d
US6924400B2 (en) *	2001-12-10	2005-08-02	Galderma Research & Development, Snc	Triaromatic vitamin D analogues
US7601850B2 (en) *	2002-05-29	2009-10-13	Eli Lilly And Company	Phenyl-thiophene type vitamin D receptor modulators
CA2496362C (en) *	2002-08-27	2012-03-06	Galderma Research & Development, S.N.C.	Analogues of vitamin d
FR2843962B1 (fr) *	2002-08-27	2005-12-02	Galderma Res & Dev	Analogues de la vitamine d
WO2005027930A1 (en) *	2003-09-19	2005-03-31	Pfizer Products Inc.	2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma
AU2004294728A1 (en)	2003-11-21	2005-06-16	Galderma Research & Development, S.N.C.	Sprayable composition for the administration of vitamin D derivatives
FR2870238B1 (fr) *	2004-05-14	2008-07-04	Galderma Res & Dev	Nouveaux derives 7,7-disubstitues du (5h,9h)-6,8- dioxabenzocycloheptene, leur preparation et leur utilisation dans la synthese d'analogues non steroidiens de la vitamine d
DE602005021484D1 (de) *	2004-05-14	2010-07-08	Galderma Res & Dev	Neuartige 7,7-disubstituierte derivate von (5h,9h)-6,8-dioxabenzocyclohepten, herstellungsverfahren dafür und ihre verwendung in der synthese von nicht-steroidalen vitamin-d-analogen
US20070299041A1 (en) *	2004-05-26	2007-12-27	Cedars-Sinai Medical Center	Induction of innate immunity by vitamin d3 and its analogs
KR20180122750A (ko) *	2004-09-02	2018-11-13	제넨테크, 인크.	헤지호그 신호전달에 대한 피리딜 억제제
CN101217868A (zh) *	2005-05-10	2008-07-09	德米普瑟尔有限公司	用于皮肤护理的组合物和方法
DK1879595T3 (en) *	2005-05-10	2015-01-05	Dermipsor Ltd	Preparations and Methods for the Treatment of Hyperproliferative Epidermal Diseases
JP5008928B2 (ja) *	2005-10-31	2012-08-22	三ツ星ベルト株式会社	プーリ構造体
WO2008083389A1 (en) *	2006-12-29	2008-07-10	Moleculin, L.L.C.	Methods of treating skin disorders with caffeic acid analogs
US8450337B2 (en) *	2008-09-30	2013-05-28	Moleculin, Llc	Methods of treating skin disorders with caffeic acid analogs
EA201691980A1 (ru)	2009-01-27	2017-07-31	БЕРГ ЭлЭлСи	Способы уменьшения побочных эффектов, связанных с химиотерапией
US8470304B2 (en)	2009-08-04	2013-06-25	Avidas Pharmaceuticals Llc	Therapeutic vitamin D sun-protecting formulations and methods for their use
KR101880032B1 (ko)	2009-08-14	2018-07-20	베르그 엘엘씨	탈모증 치료용 비타민 ｄ3 및 이의 유사체들
CA2913543C (en)	2013-05-29	2024-01-09	Berg Llc	Preventing or mitigating chemotherapy induced alopecia using vitamin d
GB201705686D0 (en) *	2017-04-07	2017-05-24	Centauri Therapeutics Ltd	Novel compounds and therapeutic uses thereof
US11612580B2 (en)	2017-10-16	2023-03-28	The Board Of Regents Of The University Of Texas System	Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions
CN109738252B (zh) *	2019-01-23	2021-03-09	深圳天辰医疗科技有限公司	25-羟基-维生素d解离液
CN109696435B (zh) *	2019-01-25	2021-03-09	深圳天辰医疗科技有限公司	维生素d的测定方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ231735A (en) *	1988-12-23	1992-04-28	Ici Plc	Alcohol/ether derivatives, preparation and pharmaceutical compositions thereof
FR2713637B1 (fr) *	1993-12-15	1996-01-05	Cird Galderma	Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
WO1995027692A1 (en) *	1994-04-08	1995-10-19	Smithkline Beecham Corporation	Subtituted biphenyl tnf inhibitors
JPH08188650A (ja) *	1995-01-13	1996-07-23	Idemitsu Kosan Co Ltd	液晶共重合体の製造方法
FR2730995B1 (fr) *	1995-02-23	1997-04-04	Cird Galderma	Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
WO1998020866A2 (en) *	1996-11-13	1998-05-22	Gill Parkash S	Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists
FR2763588B1 (fr) *	1997-05-23	1999-07-09	Cird Galderma	Composes triaromatiques, compositions les contenant et utilisations
FR2776659B1 (fr) *	1998-03-31	2000-05-26	Cird Galderma	Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
FR2776657B1 (fr) *	1998-03-31	2000-05-26	Cird Galderma	Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
US6541669B1 (en) *	1998-06-08	2003-04-01	Theravance, Inc.	β2-adrenergic receptor agonists
CN1561990A (zh) *	1999-03-22	2005-01-12	免疫力药品有限公司	治疗免疫疾病
US6442367B1 (en) *	1999-05-31	2002-08-27	Konica Corporation	Electrophotographic image forming method, electrophotographic image forming apparatus, and processing cartridge
US6683115B2 (en) *	1999-06-02	2004-01-27	Theravance, Inc.	β2-adrenergic receptor agonists
US6342642B1 (en) *	1999-11-09	2002-01-29	Basf Aktiengesellschaft	1,4-diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2-fluoro-2-butene compounds

1999
- 1999-11-24 FR FR9914781A patent/FR2801305B1/fr not_active Expired - Fee Related
2000
- 2000-11-22 CN CNB008184585A patent/CN1213980C/zh not_active Expired - Fee Related
- 2000-11-22 TR TR2004/01603T patent/TR200401603T4/xx unknown
- 2000-11-22 AU AU25222/01A patent/AU767399B2/en not_active Ceased
- 2000-11-22 DK DK00988868T patent/DK1235777T3/da active
- 2000-11-22 PL PL364768A patent/PL207046B1/pl not_active IP Right Cessation
- 2000-11-22 SE SE00988868T patent/SE1235777T5/xx unknown
- 2000-11-22 WO PCT/FR2000/003249 patent/WO2001038303A2/fr not_active Application Discontinuation
- 2000-11-22 EP EP00988868A patent/EP1235777B1/fr not_active Expired - Lifetime
- 2000-11-22 MX MXPA02005175A patent/MXPA02005175A/es active IP Right Grant
- 2000-11-22 BR BR0015924-7A patent/BR0015924A/pt active Search and Examination
- 2000-11-22 PT PT00988868T patent/PT1235777E/pt unknown
- 2000-11-22 CA CA002392165A patent/CA2392165C/fr not_active Expired - Fee Related
- 2000-11-22 JP JP2001539859A patent/JP3822106B2/ja not_active Expired - Fee Related
- 2000-11-22 CN CNB2004100789841A patent/CN100522943C/zh not_active Expired - Fee Related
- 2000-11-22 KR KR1020027006574A patent/KR100599069B1/ko not_active IP Right Cessation
- 2000-11-22 ES ES00988868T patent/ES2223642T3/es not_active Expired - Lifetime
- 2000-11-22 US US10/130,941 patent/US6831106B1/en not_active Expired - Fee Related
- 2000-11-22 DE DE60011669T patent/DE60011669T2/de not_active Expired - Lifetime
- 2000-11-22 AT AT00988868T patent/ATE269289T1/de active
- 2000-11-22 RU RU2002116690A patent/RU2237651C2/ru not_active IP Right Cessation
- 2000-11-23 AR ARP000106191A patent/AR043279A1/es active IP Right Grant
2002
- 2002-05-02 ZA ZA200203475A patent/ZA200203475B/en unknown

Also Published As

Publication number	Publication date
BR0015924A (pt)	2002-08-06
CN1423627A (zh)	2003-06-11
JP2003514892A (ja)	2003-04-22
CA2392165A1 (fr)	2001-05-31
TR200401603T4 (tr)	2004-08-23
AU2522201A (en)	2001-06-04
DK1235777T3 (da)	2004-09-20
MXPA02005175A (es)	2003-01-28
WO2001038303A3 (fr)	2002-01-17
AU767399B2 (en)	2003-11-06
KR100599069B1 (ko)	2006-07-12
CA2392165C (fr)	2008-08-26
CN100522943C (zh)	2009-08-05
CN1213980C (zh)	2005-08-10
JP3822106B2 (ja)	2006-09-13
WO2001038303A2 (fr)	2001-05-31
DE60011669T2 (de)	2005-06-30
AR043279A1 (es)	2005-07-27
SE1235777T5 (pl)	2004-09-21
RU2237651C2 (ru)	2004-10-10
ATE269289T1 (de)	2004-07-15
DE60011669D1 (de)	2004-07-22
FR2801305A1 (fr)	2001-05-25
SE1235777T3 (pl)	2004-08-03
ES2223642T3 (es)	2005-03-01
CN1616452A (zh)	2005-05-18
FR2801305B1 (fr)	2002-12-06
EP1235777A2 (fr)	2002-09-04
KR20020056944A (ko)	2002-07-10
US6831106B1 (en)	2004-12-14
PT1235777E (pt)	2004-11-30
PL207046B1 (pl)	2010-10-29
EP1235777B1 (fr)	2004-06-16
ZA200203475B (en)	2003-04-01

Publication	Publication Date	Title
HK1043588A1 (en)	2002-09-20	Vitamin d analogues
HUP0202812A3 (en)	2005-01-28	Novel bicyclonucleoside analogues
PL364768A1 (pl)	2004-12-13	Analogi witaminy D
DE50002490D1 (en)	2003-07-10	Polyester-polyetherblockcopolymere
IL140421A (en)	2003-11-23	Aircraft
DE50002614D1 (en)	2003-07-24	Sigma-delta-modulator
PL355432A1 (pl)	2004-04-19	Analogi witaminy D
GC0000198A (en)	2006-03-29	Vitamin d3 analogs
DE50000137D1 (en)	2002-05-16	Spirofluorenopyrane
PL369899A1 (pl)	2005-05-02	Analogi witaminy D
DE10081629D2 (en)	2003-03-13	Seilzugbefestigung
AU141428S (en)	2000-08-14	Turnpiece
GB0022877D0 (en)	2000-11-01	Analogues
AU140373S (en)	2000-04-12	Bumbag
PL356301A1 (pl)	2004-06-28	Nowe analogi witaminy D
GB9903377D0 (en)	1999-04-07	Amphibious-tricycle (amphi-trike)
DE50005334D1 (en)	2004-03-25	Tricyclische benzoylcyclohexandion-derivate
TW520740U (en)	2003-02-11	Escalator
GB9925815D0 (en)	1999-12-29	Divided sauce-pan
SI1200399T1 (en)	2004-06-30	Vitamin d3 analogs
GB9924096D0 (en)	1999-12-15	Supplement
GB9919023D0 (en)	1999-10-13	Ospro-ski flight
SI1023263T1 (en)	2002-12-31	Novel vitamin d analogues
AU138952S (en)	1999-11-30	Handrail
GB9918373D0 (en)	1999-10-06	Molliboard (floodbarrier)

Legal Events

Date	Code	Title	Description
2011-02-28	VDSO	Invalidation of derivated patent or utility model	Ref document number: 386824 Country of ref document: PL Kind code of ref document: A1
2013-05-31	RECP	Rectifications of patent specification

Date

Code

Title

Description

2011-02-28

VDSO

Invalidation of derivated patent or utility model

Ref document number: 386824

Country of ref document: PL

Kind code of ref document: A1

2013-05-31

RECP

Rectifications of patent specification